143503-05-3 Benzoic acid, 2-[[[(carboxymethyl)amino]oxoacetyl]amino]-
143492-65-3 D-Threonine, N-(3,5-dinitrobenzoyl)-
143494-06-8 Stannane, (bicyclo[2.2.1]hept-2-ylmethyl)tributyl-, endo-
143494-28-4 Lithium, [2-(aminomethyl)phenyl]-
143494-72-8 quinoline, 2-ethyl-4-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methoxy]-
143499-01-8 Al.Cl.Cu
143499-13-2 Ba.Bi.Ca.Cu.Li.O.Sr
143499-14-3 Ba.Bi.Ca.Cu.Mg.O.Sr.Ti
143499-71-2 (50% Dimethylsilane) - phenylmethylsilane copolymer
143499-84-7 2,2':5',2''-Terthiophene, 5-ethenyl-
143500-50-9 7-Oxabicyclo[4.1.0]hept-3-en-2-one, 5-hydroxy-3-(3-methyl-3-butenyl)-
14350-05-1 1H-Indene-2-aceticacid, 2,3-dihydro-1,3-dioxo-2-phenyl-, 2-(diethylamino)ethyl ester,hydrochloride (1:1)
143500-93-0 Nickel(2+), tetrakis(2,4-dimethylpyridine)-, dithiocyanate
1435-01-4 Hydrazinecarbothioamide, N-phenyl-2-(2-thienylmethylene)-
143501-78-4 1H-PYRROLE,1-(BROMOACETYL)-
143502-00-5 MyrigaloneH
Contacter Mrs.Camila Email Us
Mobile +86 18136843696
Tel +86 25 5874 5998
QQ 3461339351
WeChat +86 18136843696
Skype live:.cid.6d3c4ae5f7de0a26
Social Media
Serving Advanced Chemicals to Global Customers
© 2009 - 2025 USCKS | King-Pharm Ver 3.0